Free Trial

Teleflex Incorporated (NYSE:TFX) Director Gretchen R. Haggerty Purchases 500 Shares

Teleflex logo with Medical background

Key Points

  • Gretchen R. Haggerty, Director of Teleflex, acquired 500 shares of the company's stock on August 6th for a total of $57,375, increasing her ownership by 8.61%.
  • Teleflex recently reported earnings per share (EPS) of $3.73, surpassing analysts' expectations of $3.36, with revenues of $780.90 million up 4.2% year-over-year.
  • The company has announced a quarterly dividend of $0.34 per share to be paid on September 15th, reflecting an annualized yield of 1.2%.
  • Need better tools to track Teleflex? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Gretchen R. Haggerty acquired 500 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was acquired at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the transaction, the director owned 6,305 shares in the company, valued at approximately $723,498.75. The trade was a 8.61% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Teleflex Stock Performance

Shares of NYSE:TFX traded down $0.85 during trading on Monday, reaching $117.57. 16,693 shares of the company's stock traded hands, compared to its average volume of 801,558. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $249.90. The company has a 50 day moving average of $118.09 and a 200-day moving average of $134.28. The stock has a market capitalization of $5.20 billion, a P/E ratio of 27.83, a price-to-earnings-growth ratio of 1.65 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same period in the prior year, the business posted $3.42 EPS. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. On average, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be paid a $0.34 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.2%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Analyst Ratings Changes

TFX has been the subject of several recent research reports. Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Morgan Stanley dropped their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Wells Fargo & Company lowered their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Truist Financial reduced their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Finally, Mizuho lifted their price objective on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Teleflex has an average rating of "Hold" and a consensus price target of $141.57.

View Our Latest Stock Report on TFX

Institutional Trading of Teleflex

A number of hedge funds have recently bought and sold shares of the stock. Headlands Technologies LLC acquired a new stake in shares of Teleflex during the 4th quarter worth approximately $29,000. Resona Asset Management Co. Ltd. bought a new position in Teleflex in the fourth quarter valued at approximately $2,471,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Teleflex in the fourth quarter worth $272,000. Russell Investments Group Ltd. lifted its position in shares of Teleflex by 116.9% in the fourth quarter. Russell Investments Group Ltd. now owns 89,194 shares of the medical technology company's stock worth $15,870,000 after purchasing an additional 48,064 shares in the last quarter. Finally, Cerity Partners LLC raised its position in Teleflex by 25.8% during the fourth quarter. Cerity Partners LLC now owns 16,822 shares of the medical technology company's stock worth $3,266,000 after acquiring an additional 3,448 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines